Where does Galapagos NV rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Galapagos NV ranks #4,240 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Galapagos NV hold?

Galapagos NV holds 84 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is Galapagos NV's Innovation Score?

Galapagos NV has an Innovation Score of 41.2 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Galapagos NV's patent grant rate increasing or decreasing?

Galapagos NV's recent grant velocity is -42% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Galapagos NV's patents?

Galapagos NV's patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Galapagos NV patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Galapagos NV

Q: What technology areas does Galapagos NV focus on?

Galapagos NV's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 84 patents. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 84 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Galapagos ranks #4,240 of 49,997 tracked US assignees by granted-patent volume, with 84 patents across 14 technology areas.

#4,240
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.2/100): 17.9
avg claims per patent: -42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4240 · Foreign Corporation #4,240 · 84 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 84 grants
TOP-DECILE #4,240/49,997
PHOTO-FINISH Festo & KG
CPC-FOCUS A61P · 14 areas
INNOV-PAR 41.2/100
CLAIMS-RICH 17.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -42% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Festo AG & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Capital One Financial · near

41
Control Techniques · near

41
Galapagos · this assignee

41
Mersana Therapeutics · near

41
Surpass Industry · near

41
3D Lighting… · lowest

7

What this shows Galapagos's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Galapagos's grants concentrate

Galapagos NV is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (16 grants) versus a trough of 3 in 2022. By volume, Galapagos sits between Flipboard, Inc. and Inovio Pharmaceuticals, Inc..

Galapagos's three-year grant acceleration

From 2019–2021 to 2022–2024, Galapagos NV moved from 32 to 9 grants (0.28x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Flipboard

84
Festo & KG

84
GN Netcom A/S

84
Guangdong Gopod G…

84
Ignite USA

84
Imra America

84
Inmar Clearing

84
Inovio Pharmaceut…

84
Galapagos ◀

84

What this shows Galapagos holds 84 patents at rank #4,242, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Galapagos

By rank, the assignees closest to #4,242 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Galapagos's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Galapagos, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Surpass Industry Co., Ltd. 41 Capital One Financial Corporation 41 Control Techniques Limited 41 Mersana Therapeutics, Inc. 41

Similar claim depth

Nearest assignees by average claims per patent (17.9 here).

Inguran, LLC 17.9 avg 23andMe, Inc. 17.9 avg Cigna Intellectual Property, Inc. 17.9 avg The University Of North Carolina At Charlotte 17.9 avg

Galapagos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Galapagos NV patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	7.1%
2016	11	13.1%
2017	8	9.5%
2018	16	19.0%
2019	11	13.1%
2020	14	16.7%
2021	7	8.3%
2022	3	3.6%
2023	3	3.6%
2024	3	3.6%
2025partial year	2	2.4%

Which technologies does Galapagos NV patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 84

C07D - Heterocyclic Compounds 72

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 71

C07K - Peptides 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07C - Acyclic OR Carbocyclic Compounds 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

H04W - Wireless Communication Networks 4

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 4

C12Y - Enzymes 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#4,240

of 49,997 tracked assignees

Innovation Score

41.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Galapagos NV's patent record in context - here's where to go next.

Galapagos NV's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #4,240 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Galapagos NV against Flipboard, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.